THE DEAL, AT A GLANCE
From the announcementEncoded Therapeutics
01Who is involvedBacked by firms like Venrock, ARCH Venture Partners, Reports Broader Portfolio Progress – Encoded TherapeuticsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedEncoded Therapeutics raised $275M Series F, announced 2026-09-09From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersEncoded Therapeutics raised $275 Million in Series F financing to advance ETX101 through pivotal development for Dravet syndrome and accelerate its precision genetic…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Encoded Therapeutics · Financing Record
Explore source-linked visual explanations for Encoded Therapeutics. Unsupported claims are withheld while source review continues.
Record 11940 · Recorded date: 2026-09-09
Explore company records →